Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q4 2025 | 22.52% |
| Q3 2025 | 12.94% |
| Q2 2025 | 21.05% |
| Q1 2025 | -20.72% |
| Q4 2024 | 8.83% |
| Q3 2024 | 0.31% |
| Q2 2024 | -6.64% |
| Q1 2024 | 1.14% |
| Q4 2023 | -16.07% |
| Q3 2023 | 9.22% |
| Q2 2023 | 18.68% |
| Q1 2023 | -12.21% |
| Q4 2022 | -2.38% |
| Q3 2022 | 41559.06% |
| Q2 2022 | -1575.00% |
| Q1 2022 | 71.43% |
| Q4 2021 | 84.95% |
| Q3 2021 | -78.85% |
| Q2 2021 | -300.00% |
| Q1 2021 | 71.11% |
| Q4 2020 | -150.00% |
| Q3 2020 | 78.57% |
| Q2 2020 | -100.71% |
| Q1 2020 | 35061.76% |
| Q4 2019 | 99.66% |
| Q3 2019 | 10.66% |
| Q2 2019 | 7.62% |
| Q1 2019 | -45.87% |
| Q4 2018 | -47.89% |
| Q3 2018 | -43.35% |
| Q2 2018 | -3.29% |
| Q1 2018 | -16.10% |
| Q4 2017 | 7.00% |
| Q3 2017 | -5.99% |
| Q2 2017 | -83.80% |
| Q1 2017 | 12.30% |
| Q4 2016 | 37.91% |
| Q3 2016 | -24.37% |
| Q2 2016 | -21.41% |
| Q1 2016 | -31.38% |